Literature DB >> 12382031

Hemodialysis improves myocardial interstitial edema and left ventricular diastolic function in patients with end-stage renal disease: noninvasive assessment by ultrasonic tissue characterization.

Kaniz Fatema1, Osamu Hirono, Yasuchika Takeishi, Joji Nitobe, Kazuyoshi Kaneko, Minoru Ito, Ikuto Masakane, Isao Kubota.   

Abstract

Congestive heart failure is the most common cause of mortality in patients with end-stage renal disease (ESRD). Ultrasonic tissue characterization with integrated backscatter offers a promising method for the noninvasive assessment of regional myocardial contractile performance and fibrosis. The aim of this study was to investigate the effect of hemodialysis (HD) on myocardial tissue characterization and left ventricular function in ESRD patients. We examined 26 patients with ESRD undergoing routine HD (age 63 +/- 12 years, duration of HD 9.2 +/- 3.2 years) and 30 patients with essential hypertension (HT; 60 +/- 10 years). Routine echocardiographic parameters and the cyclic variation of ultrasonic integrated backscatter of the ventricular septum (CV-IBS) were measured. Left ventricular mass index was significantly larger in patients with ESRD than in those with HT (217 +/- 56 vs 146 +/- 45 g/m(2), P < 0.05). The indices for left ventricular diastolic function (E/A, the ratio of left ventricular peak early to late diastolic filling velocity; DT, the deceleration time of the early diastolic filling) and CV-IBS had deteriorated significantly in patients with ESRD before HD compared with those with HT (E/A, 0.6 +/- 0.2 vs 0.9 +/- 0.3, P < 0.05; DT, 228 +/- 23 vs 184 +/- 19 ms, P < 0.05; CV-IBS, 9.0 +/- 1.3 vs 12.4 +/- 0.9 dB, P < 0.05), possibly reflecting interstitial fibrosis. In patients with ESRD, HD reduced calculated left ventricular mass index by 19% (before HD, 217 +/- 56 vs immediately after HD, 176 +/- 45 g/m(2), P < 0.05) and CV-IBS by 19% (9.0 +/- 1.3 vs 7.3 +/- 1.1 dB, P < 0.05), that possibly reflected improvement of interstitial edema. HD also significantly improved indices for left ventricular diastolic function (E/A, 0.6 +/- 0.2 vs 0.9 +/- 0.2, P < 0.05; DT, 228 +/- 23 vs 188 +/- 21 ms, P < 0.05). HD improves myocardial interstitial edema and left ventricular diastolic function in patients with ESRD. Noninvasive assessment of ultrasonic tissue characterization is useful in defining the pathophysiological changes of ventricular myocardium in patients with ESRD.

Entities:  

Mesh:

Year:  2002        PMID: 12382031     DOI: 10.1007/s003800200029

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  5 in total

1.  The impact of kidney transplantation on heart failure risk varies with candidate body mass index.

Authors:  Krista L Lentine; Huiling Xiao; Daniel C Brennan; Mark A Schnitzler; Todd C Villines; Kevin C Abbott; David Axelrod; Jon J Snyder; Paul J Hauptman
Journal:  Am Heart J       Date:  2009-12       Impact factor: 4.749

2.  Effect of maintenance hemodialysis on diastolic left ventricular function in end-stage renal disease.

Authors:  Mustafa Duran; Aydin Unal; Mehmet Tugrul Inanc; Fatma Esin; Yucel Yilmaz; Ender Ornek
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

3.  Differing myocardial response to a single session of hemodialysis in end-stage renal disease with and without type 2 diabetes mellitus and coronary artery disease.

Authors:  Satish Chandra Govind; Simin Roumina; Lars-Ake Brodin; Jacek Nowak; Saligrama Srinivasiah Ramesh; Samir Kanti Saha
Journal:  Cardiovasc Ultrasound       Date:  2006-02-02       Impact factor: 2.062

4.  [Heart failure with preserved ejection fraction in sub-Saharan Africa: about 32 cases].

Authors:  Mouhamed Cherif Mboup; Khadidiatou Dia; Pape Diadie Fall
Journal:  Pan Afr Med J       Date:  2013-11-16

5.  The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.

Authors:  Huayan Xu; Wanlin Peng; Zhigang Yang; Yingkun Guo; Yi Zhang; Chunchao Xia; Zhenlin Li; Rong Xu
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-11       Impact factor: 5.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.